News

Colombia pushes for pharmaceutical self-sufficiency
Driven by lessons from the pandemic and a reliance on imports -- more than $2.16 billion in packaged medicines in 2023, most ...
EU-US trade deal could add up to $19 billion in pharma industry costs, analysts say
The European Union's trade deal with the United States could cost the pharmaceutical industry between $13 billion and $19 ...
Chemistry World2d
Ten years on, pharma industry still testing for implausible alkyl sulfonate ester contaminants in drugs
Risk assessment for potential mutagenic side-products is still required by regulatory bodies, despite lack of evidence they ...
BioSpace13hOpinion
Opinion: How AI Can Help Pharma Companies Adapt to Policy Pressures
The regulatory environment is placing extreme pricing pressure on pharmaceutical manufacturers. Their success in the market ...
StockStory.org on MSN6h
Royalty Pharma (NASDAQ:RPRX) Misses Q2 Revenue Estimates
Healthcare royalties company Royalty Pharma (NASDAQ:RPRX) in Q2 CY2025, but sales rose 7.8% year on year to $579 million. Its ...
Pharmaceutical industry still in the dark over 200% tariffs
The Canadian pharmaceutical industry is still waiting to learn about tariffs as high as 200 per cent on exports to the U.S.
China Daily5h
Pharmaceutical levies won't prompt reshoring: China Daily editorial
The US initiated a Section 232 investigation on pharmaceutical products in April, purportedly to verify the impact of imports ...
Pharma prepared to work with Trump on DTC drug sales: Pfizer CEO
Pfizer's Albert Bourla told investors that major drugmakers are "ready to roll up their sleeves" and build out more direct-to ...